These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22299599)

  • 21. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial.
    Kangasniemi MH; Arffman RK; Joenväärä S; Haverinen A; Luiro K; Tohmola T; Renkonen R; Heikinheimo O; Tapanainen JS; Piltonen TT
    Hum Reprod; 2023 Jan; 38(1):89-102. PubMed ID: 36416543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
    Kaunitz AM; Portman D; Westhoff CL; Archer DF; Mishell DR; Foegh M
    Contraception; 2015 Mar; 91(3):204-10. PubMed ID: 25582984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
    Spona J; Feichtinger W; Kindermann C; Wünsch C; Brill K
    Contraception; 1996 Nov; 54(5):299-304. PubMed ID: 8934064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    Zimmerman Y; Coelingh Bennink HJ; Wouters W; Ebes F; Fauser BC
    Eur J Contracept Reprod Health Care; 2013 Dec; 18(6):489-500. PubMed ID: 23944295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
    Jonderko K; Skałba P; Kasicka-Jonderko A; Kamińska M; Bizior-Frymus D; Dyja R
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):284-92. PubMed ID: 23642250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.
    Elgart A; Zur AA; Mimrod D; Dror V; Bar-Ilan O; Korver T; Spiegelstein O
    Eur J Clin Pharmacol; 2019 Jan; 75(1):41-49. PubMed ID: 30191262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
    Kroll R; Seidman L; Ricciotti N; Howard B; Weiss H
    Eur J Contracept Reprod Health Care; 2015; 20(4):249-58. PubMed ID: 25522805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
    Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
    Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W; Mellinger U; Parke S; Serrani M
    Clin Drug Investig; 2011; 31(8):573-584. PubMed ID: 21721593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.
    Palovaara S; Kivistö KT; Tapanainen P; Manninen P; Neuvonen PJ; Laine K
    Br J Clin Pharmacol; 2000 Oct; 50(4):333-7. PubMed ID: 11012556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats.
    Aremu AO; Lilian DC; Olufemi SA; Aderemi OL
    J Renin Angiotensin Aldosterone Syst; 2019; 20(4):1470320319895933. PubMed ID: 31856649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB; Fruzzetti F; Nicoletti I; Ricci C; Lammers P; Atsma WJ; Fioretti P
    Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S; Chen JK; He ML; Fotherby K
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function.
    Duijkers I; Killick S; Bigrigg A; Dieben TO
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):131-40. PubMed ID: 15697102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.